FDA Approves Vera Therapeutics' Trutakna For Treatment Of Proteinuria In Adults With Primary Immunoglobulin A Nephropathy

Benzinga Newsdesk www.benzinga.com Neutral 90.5%

Neg 0% Neu 90.5% Pos 0%

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-new-treatment-reduce-proteinuria-adults-primary-immunoglobulin-nephropathy